MannKind | MNKD - Валовая прибыль





Валовая прибыль Изменить Дата
Adma Biologics USD 80.75M 8.07M 2026-03
BioCryst Pharmaceuticals USD 214.41M 61.36M 2026-06
Eli Lilly USD 16.22B 301.7M 2026-03
Halozyme Therapeutics USD 297.47M 75.53M 2026-03
Insmed USD 356.19M 99.73M 2026-06
Karyopharm Therapeutics USD 33.72M 1.13M 2026-03
MacroGenics USD 11.24M 19.87M 2026-03
MannKind USD 7.77M 60.56M 2026-06
Merck USD 12.09B 1.24B 2026-03
Minerva Neurosciences -4.27M 26.79M 2024-12
Novavax USD 125.04M 76.09M 2025-12
Novo Nordisk DKK 83.22B 19.21B 2026-03
Pfizer USD -248M 11.29B 2026-06
Sanofi EUR 8.71B 602M 2026-06
Xencor USD 51.22M 46.7M 2026-06